| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0009 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |